Global Pharmaceutical Stability & Storage Services Market is valued at approximately USD 2.7 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.5% over the forecast period 2022-2028. Pharmaceutical firms, biotech companies, contract research groups, and other end-users relied heavily on worldwide pharmaceutical stability and storage service providers. These organisations have been working hard to generate pharmaceutical samples, APIs, small and big compounds, and other pharmaceutical goods. Because of the high burden of chronic and infectious diseases, the global industry has seen significant expansion as a result of growing R&D spending by pharmaceutical companies. Pharmaceutical companies are increasingly relying on R&D to remain competitive and versatile. According to Evaluate Pharma, pharmaceutical R&D investment amounted to USD 182 billion in 2018, with a 16.5 percent increase to USD 212 billion in 2021. The government's growing vaccine campaign is likely to increase demand for commercial COVID-19 vaccine stability and storage. Pharmaceutical R&D spending has increased significantly in recent years. The number of drugs in the clinical stage is expected to increase as R&D spending increases. Each phase of a clinical trial must pass stability testing before it can be approved. This is fueling the market's expansion. Also, the increasing global burden of these diseases is likely to drive demand for biosimilars and, as a result, demand for biosimilar stability and storage. Different regulatory agencies have different data requirements and testing criteria for assessing stability, which makes marketing products problematic, especially across markets.
The key regions considered for the global Pharmaceutical Stability & Storage Services market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the pharmaceutical stability and storage industry. This is due to a large number of pharmaceutical businesses in the United States and Canada. The presence of prominent market players in this region providing stability and storage services is projected to considerably contribute to market growth. Over the projection period, Asia Pacific is expected to develop at the fastest CAGR because of the existence of countries such as China, India, and Japan, the area has the fastest expanding pharmaceutical market. Initiatives by public entities to cut drug prices in order to improve access to quality medicines have contributed to market growth.
Major market players included in this report are:
Catalent Inc.
Almac Group
Charles River Laboratories International, Inc.
Eurofins Scientific SE
Intertek Group plc
Lucideon Limited
Alcami Corporation
Element Materials Technology
BioLife Solutions
Q1 Scientific
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Services:
Stability
Storage
By Molecule:
Small Molecule
Large Molecule
By Mode:
In-house
Outsourcing
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Pharmaceutical Stability & Storage Services Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
- 1.2.1. Pharmaceutical Stability & Storage Services Market, by Region, 2020-2028 (USD Billion)
- 1.2.2. Pharmaceutical Stability & Storage Services Market, by Services, 2020-2028 (USD Billion)
- 1.2.3. Pharmaceutical Stability & Storage Services Market, by Molecule, 2020-2028 (USD Billion)
- 1.2.4. Pharmaceutical Stability & Storage Services Market, by Mode, 2020-2028 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Pharmaceutical Stability & Storage Services Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Pharmaceutical Stability & Storage Services Market Dynamics
- 3.1. Pharmaceutical Stability & Storage Services Market Impact Analysis (2020-2028)
- 3.1.1. Market Drivers
- 3.1.1.1. High R&D spending of pharmaceutical & biotechnology companies
- 3.1.1.2. Growing demand for outsourcing stability testing due to high complexity associated with drug stability
- 3.1.2. Market Challenges
- 3.1.2.1. Strict regulations for global Pharmaceutical Stability and Storage Services drugs
- 3.1.3. Market Opportunities
- 3.1.3.1. Growing demand for biosimilars
Chapter 4. Global Pharmaceutical Stability & Storage Services Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
- 4.2. PEST Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.3. Investment Adoption Model
- 4.4. Analyst Recommendation & Conclusion
- 4.5. Top investment opportunity
- 4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1.1. Assessment of the overall impact of COVID-19 on the industry
- 5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Pharmaceutical Stability & Storage Services Market, by Services
- 6.1. Market Snapshot
- 6.2. Global Pharmaceutical Stability & Storage Services Market by Services, Performance - Potential Analysis
- 6.3. Global Pharmaceutical Stability & Storage Services Market Estimates & Forecasts by Services, 2018-2028 (USD Billion)
- 6.4. Pharmaceutical Stability & Storage Services Market, Sub Segment Analysis
- 6.4.1. Stability
- 6.4.2. Storage
Chapter 7. Global Pharmaceutical Stability & Storage Services Market, by Molecule
- 7.1. Market Snapshot
- 7.2. Global Pharmaceutical Stability & Storage Services Market by Molecule, Performance - Potential Analysis
- 7.3. Global Pharmaceutical Stability & Storage Services Market Estimates & Forecasts by Molecule, 2018-2028 (USD Billion)
- 7.4. Pharmaceutical Stability & Storage Services Market, Sub Segment Analysis
- 7.4.1. Small Molecule
- 7.4.2. Large Molecule
Chapter 8. Global Pharmaceutical Stability & Storage Services Market, by Mode
- 8.1. Market Snapshot
- 8.2. Global Pharmaceutical Stability & Storage Services Market by Mode, Performance - Potential Analysis
- 8.3. Global Pharmaceutical Stability & Storage Services Market Estimates & Forecasts by Mode, 2018-2028 (USD Billion)
- 8.4. Pharmaceutical Stability & Storage Services Market, Sub Segment Analysis
- 8.4.1. In-house
- 8.4.2. Outsourcing
Chapter 9. Global Pharmaceutical Stability & Storage Services Market, Regional Analysis
- 9.1. Pharmaceutical Stability & Storage Services Market, Regional Market Snapshot
- 9.2. North America Pharmaceutical Stability & Storage Services Market
- 9.2.1. U.S. Pharmaceutical Stability & Storage Services Market
- 9.2.1.1. Services breakdown estimates & forecasts, 2018-2028
- 9.2.1.2. Molecule breakdown estimates & forecasts, 2018-2028
- 9.2.1.3. Mode breakdown estimates & forecasts, 2018-2028
- 9.2.2. Canada Pharmaceutical Stability & Storage Services Market
- 9.3. Europe Pharmaceutical Stability & Storage Services Market Snapshot
- 9.3.1. U.K. Pharmaceutical Stability & Storage Services Market
- 9.3.2. Germany Pharmaceutical Stability & Storage Services Market
- 9.3.3. France Pharmaceutical Stability & Storage Services Market
- 9.3.4. Spain Pharmaceutical Stability & Storage Services Market
- 9.3.5. Italy Pharmaceutical Stability & Storage Services Market
- 9.3.6. Rest of Europe Pharmaceutical Stability & Storage Services Market
- 9.4. Asia-Pacific Pharmaceutical Stability & Storage Services Market Snapshot
- 9.4.1. China Pharmaceutical Stability & Storage Services Market
- 9.4.2. India Pharmaceutical Stability & Storage Services Market
- 9.4.3. Japan Pharmaceutical Stability & Storage Services Market
- 9.4.4. Australia Pharmaceutical Stability & Storage Services Market
- 9.4.5. South Korea Pharmaceutical Stability & Storage Services Market
- 9.4.6. Rest of Asia Pacific Pharmaceutical Stability & Storage Services Market
- 9.5. Latin America Pharmaceutical Stability & Storage Services Market Snapshot
- 9.5.1. Brazil Pharmaceutical Stability & Storage Services Market
- 9.5.2. Mexico Pharmaceutical Stability & Storage Services Market
- 9.6. Rest of The World Pharmaceutical Stability & Storage Services Market
Chapter 10. Competitive Intelligence
- 10.1. Top Market Strategies
- 10.2. Company Profiles
- 10.2.1. Catalent Inc.
- 10.2.1.1. Key Information
- 10.2.1.2. Overview
- 10.2.1.3. Financial (Subject to Data Availability)
- 10.2.1.4. Product Summary
- 10.2.1.5. Recent Developments
- 10.2.2. Almac Group
- 10.2.3. Charles River Laboratories International, Inc.
- 10.2.4. Eurofins Scientific SE
- 10.2.5. Intertek Group plc
- 10.2.6. Lucideon Limited
- 10.2.7. Alcami Corporation
- 10.2.8. Element Materials Technology
- 10.2.9. BioLife Solutions
- 10.2.10. Q1 Scientific
Chapter 11. Research Process
- 11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
- 11.2. Research Attributes
- 11.3. Research Assumption